Common cold: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett (Started Treatment section) |
imported>Robert Badgett No edit summary |
||
| Line 1: | Line 1: | ||
{{subpages}} | {{subpages}} | ||
The common cold is a "catarrhal<ref>Inflammation of the nose and throat with increased production of mucus.</ref> disorder of the upper respiratory tract, which may be viral, a mixed infection, or an allergic reaction. It is marked by acute coryza,<ref> inflammation of the mucous membrane lining the nose (usually associated with nasal discharge).</ref> slight rise in [[fever|temperature]], chilly sensations, and general indisposition."<ref>{{MeSH}}</ref> | The common cold is a "catarrhal<ref>Inflammation of the nose and throat with increased production of mucus.</ref> disorder of the upper respiratory tract, which may be viral, a mixed infection, or an allergic reaction. It is marked by acute coryza,<ref> inflammation of the mucous membrane lining the nose (usually associated with nasal discharge).</ref> slight rise in [[fever|temperature]], chilly sensations, and general indisposition."<ref>{{MeSH}}</ref> | ||
==Diagnosis== | |||
The [[United States]] [[Food and Drug Administration]] has approved xTAG™ Respiratory Viral Panel (RVP) for detecting viral causes.<ref name="urlK063765">{{cite web |url=http://www.fda.gov/cdrh/mda/docs/K063765.html |title=New Device Approval - xTAG™ Respiratory Viral Panel (RVP) - K063765 |author=Anonymous |authorlink= |coauthors= |date=2008 |format= |work= |publisher=Food and Drug Administration |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=2008-11-04}}</ref> | |||
==Treatment== | ==Treatment== | ||
[[Naproxen]], a [[non-steroidal anti-inflammatory agent]], may reduce "symptoms of [[headache]], malaise, myalgia, and [[cough]]".<ref name="pmid1317694">{{cite journal |author=Sperber SJ, Hendley JO, Hayden FG, Riker DK, Sorrentino JV, Gwaltney JM |title=Effects of naproxen on experimental rhinovirus colds. A randomized, double-blind, controlled trial |journal=Ann. Intern. Med. |volume=117 |issue=1 |pages=37-41 |year=1992 |pmid=1317694 |doi=}}</ref> | [[Naproxen]], a [[non-steroidal anti-inflammatory agent]], may reduce "symptoms of [[headache]], malaise, myalgia, and [[cough]]".<ref name="pmid1317694">{{cite journal |author=Sperber SJ, Hendley JO, Hayden FG, Riker DK, Sorrentino JV, Gwaltney JM |title=Effects of naproxen on experimental rhinovirus colds. A randomized, double-blind, controlled trial |journal=Ann. Intern. Med. |volume=117 |issue=1 |pages=37-41 |year=1992 |pmid=1317694 |doi=}}</ref> | ||
Regarding over-the-counter (OTC) medications, "there is no good evidence for or against the effectiveness of OTC medicines in acute cough" according to a [[systematic review]] by the [[Cochrane Collaboration]].<ref name="pmid18253996">{{cite journal |author=Smith SM, Schroeder K, Fahey T |title=Over-the-counter medications for acute cough in children and adults in ambulatory settings |journal=Cochrane Database Syst Rev |volume= |issue=1 |pages=CD001831 |year=2008 |pmid=18253996 |doi=10.1002/14651858.CD001831.pub3 |url=http://dx.doi.org/10.1002/14651858.CD001831.pub3 |issn=}}</ref> | |||
"[[Pelargonium sidoides|P. sidoides]] may be effective in alleviating symptoms of acute rhinosinusitis and the [[common cold]] in adults, but doubt exists," according to a [[systematic review]] by the [[Cochrane Collaboration]].<ref name="pmid18646148">{{cite journal |author=Timmer A, Günther J, Rücker G, Motschall E, Antes G, Kern WV |title=Pelargonium sidoides extract for acute respiratory tract infections |journal=Cochrane Database Syst Rev |volume= |issue=3 |pages=CD006323 |year=2008 |pmid=18646148 |doi=10.1002/14651858.CD006323.pub2 |url=http://dx.doi.org/10.1002/14651858.CD006323.pub2 |issn=}}</ref> | |||
==References== | ==References== | ||
<references/> | <references/> | ||
Revision as of 15:21, 19 February 2009
The common cold is a "catarrhal[1] disorder of the upper respiratory tract, which may be viral, a mixed infection, or an allergic reaction. It is marked by acute coryza,[2] slight rise in temperature, chilly sensations, and general indisposition."[3]
Diagnosis
The United States Food and Drug Administration has approved xTAG™ Respiratory Viral Panel (RVP) for detecting viral causes.[4]
Treatment
Naproxen, a non-steroidal anti-inflammatory agent, may reduce "symptoms of headache, malaise, myalgia, and cough".[5]
Regarding over-the-counter (OTC) medications, "there is no good evidence for or against the effectiveness of OTC medicines in acute cough" according to a systematic review by the Cochrane Collaboration.[6]
"P. sidoides may be effective in alleviating symptoms of acute rhinosinusitis and the common cold in adults, but doubt exists," according to a systematic review by the Cochrane Collaboration.[7]
References
- ↑ Inflammation of the nose and throat with increased production of mucus.
- ↑ inflammation of the mucous membrane lining the nose (usually associated with nasal discharge).
- ↑ Anonymous (2024), Common cold (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ Anonymous (2008). New Device Approval - xTAG™ Respiratory Viral Panel (RVP) - K063765. Food and Drug Administration. Retrieved on 2008-11-04.
- ↑ Sperber SJ, Hendley JO, Hayden FG, Riker DK, Sorrentino JV, Gwaltney JM (1992). "Effects of naproxen on experimental rhinovirus colds. A randomized, double-blind, controlled trial". Ann. Intern. Med. 117 (1): 37-41. PMID 1317694. [e]
- ↑ Smith SM, Schroeder K, Fahey T (2008). "Over-the-counter medications for acute cough in children and adults in ambulatory settings". Cochrane Database Syst Rev (1): CD001831. DOI:10.1002/14651858.CD001831.pub3. PMID 18253996. Research Blogging.
- ↑ Timmer A, Günther J, Rücker G, Motschall E, Antes G, Kern WV (2008). "Pelargonium sidoides extract for acute respiratory tract infections". Cochrane Database Syst Rev (3): CD006323. DOI:10.1002/14651858.CD006323.pub2. PMID 18646148. Research Blogging.